Type 2 Diabetes Mellitus: Clinical Trials

1,890 trials for Type 2 Diabetes Mellitus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1439 completed, 210 unknown, 99 terminated, 43 recruiting. 515 Not applicable, 366 Phase 3, 281 Phase 1, 278 Phase 4, 250 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable515Completed 364, Unknown 82, Not yet recruiting 19, Terminated 15, Recruiting 12, Active not recruiting 10, Withdrawn 8, Suspended 3, Enrolling by invitation 2
Phase 3366Completed 297, Terminated 28, Unknown 21, Recruiting 10, Not yet recruiting 4, Withdrawn 4, Active not recruiting 2
Phase 1281Completed 243, Unknown 18, Terminated 10, Withdrawn 4, Active not recruiting 3, Not yet recruiting 1, Recruiting 1, Suspended 1
Phase 4278Completed 219, Unknown 30, Terminated 19, Recruiting 3, Withdrawn 3, Not yet recruiting 2, Enrolling by invitation 1, Suspended 1
Phase 2250Completed 197, Terminated 19, Unknown 18, Withdrawn 7, Active not recruiting 4, Not yet recruiting 3, Recruiting 2
Early Phase 115Completed 13, Unknown 2

Follow Type 2 Diabetes Mellitus: new trials by email Literature Review of Type 2 Diabetes Mellitus trials Research Report on Type 2 Diabetes Mellitus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing a Diabetes Care Program in Rural and Low-Income Clinics
Community Health Worker-led diabetes program - Type 2 Diabetes Mellitus
Not applicableNot yet recruitingThe University of Texas Medical Branch, Galveston2002027-03-012026-08-14
Clinical Research Trial to Study Insulin Sensitivity Using Automated Glucose Clamp Technology
Obesity Type 2 Diabetes Mellitus, Obese Adults
Not yet recruitingProfil Institut für Stoffwechselforschung GmbH502027-02-012026-11-03
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
AZD6234, Placebo - Obesity, Overweight
Phase 3Not yet recruitingAstraZeneca3302027-01-042026-11-06
Diabetes Distress, Medication Adherence Barriers, Self-Management, and Glycemic Control in Adults With Type 2 Diabetes
Diabetes Distress, Medication Adherence Barriers, Diabetes self-managemen - Type 2 Diabetes Mellitus
Not yet recruitingBilecik Seyh Edebali Universitesi1372026-12-152026-10-06
A Clinical Study to Evaluate the Effects of Enicepatide Versus Tirzepatide in Participants With Type 2 Diabetes and Inadequate Blood Sugar Control on Oral Glucose-Lowering Medications
Enicepatide, Tirzepatide - Type 2 Diabetes Mellitus
Phase 3Not yet recruitingHoffmann-La Roche9482026-12-012026-10-22
Comparison of Functional Inspiratory Muscle Training and Combined Exercise Training in Individuals With Type 2 Diabetes
Combined Excerse Training, Functional Inspiratory Muscle Training, Usual Care - Type 2 Diabetes Mellitus
Not applicableNot yet recruitingİrem Çaylak Yetüt392026-12-012026-11-06
Preventive Effectiveness of Primary Care Physician-led CGM-supported Comprehensive Intervention on Cardio-metabolic-immune Diseases in Community Patients With Type 2 Diabetes (Community Diabetes Control Project)
comprehensive intervention - Type 2 Diabetes Mellitus
Not applicableNot yet recruitingXiangya Hospital of Central South University154002026-11-302026-10-21
Sleep Quality, Adiposity and Diet Quality
Type 2 Diabetes Mellitus, Health Adult Subjects
Not yet recruitingIzmir Democracy University2092026-11-152026-10-13
A Research Study of a New Medicine NNC0662-3168 for Weight Management and Type 2 Diabetes
NNC0662-3168 (Test product-A), Placebo matched to NNC0662-3168 (Test product-A), Active Comparator (Product-B) - Overweight, Obesity
Phase 1 / Phase 2Not yet recruitingNovo Nordisk A/S3002026-11-132026-11-17
Beta-2-Trace Protein in Diabetic Nephropathy
Diabetic Nephropathy Type 2, Type 2 Diabetes Mellitus
Not yet recruitingAssiut University802026-11-102026-11-05
AI Chatbot Mobile App for Self-Management in Type 2 Diabetes
AI Chatbot-Integrated Mobile Application - Type 2 Diabetes Mellitus
Not applicableNot yet recruitingAlexandria University1202026-11-102026-11-09
Home Visits and Telephone-Supported Education for Adults With Type 2 Diabetes
Nurse-Led Home Visit-Based Diabetes Education, Nurse-Led Telephone-Supported Diabetes Education - Type 2 Diabetes Mellitus
Not applicableRecruitingSaglik Bilimleri Universitesi902026-11-102026-11-19
Clinical Decision Support for SGLT2i After AKI in Type 2 Diabetes
Clinical Decision Support Message - Type 2 Diabetes Mellitus, Acute Kidney Injury
Not applicableRecruitingUniversity of Minnesota2502026-11-022026-11-04
AI-Based Model for Predicting Type 2 Diabetes Risk Using Lifestyle Factors Among Senior Nursing Students
AI-Based Diabetes Risk Prediction Model - Type 2 Diabetes Mellitus
Not yet recruitingAlexandria University2002026-11-012026-11-04
A Nurse-Led Digital Coaching Program to Improve Blood Sugar Control in Adults With Type 2 Diabetes
ChronoCoach, Usual diabetes care - Type 2 Diabetes Mellitus
Not applicableNot yet recruitingAlexandria University1602026-11-012026-11-04
Pilates vs. Core Stabilization for Balance and Mobility in Elderly Type 2 Diabetics
Pilates Training programme - Mellitus Balance Deficits Postural Balance Mobility Limitation, Type 2 Diabetes Mellitus
Not applicableNot yet recruitingBeni-Suef University402026-10-292026-11-05
Physiologic Insulin Resensitization (PIR) Treatment in Patients With a Diagnosis of Type 2 Diabetes Mellitus (T2DM)
Physiologic insulin resensitization (PIR) - Type 2 Diabetes Mellitus
Not applicableNot yet recruitingUniversity of Alabama at Birmingham602026-10-262026-10-30
Clinical Predictors and Therapeutic Gaps in CKM Syndrome Among Adults With Type 2 Diabetes
clinical and laboratory CKM staging evaluation - Type 2 Diabetes Mellitus, Cardiovascular-Kidney-Metabolic Syndrome
Not yet recruitingAssiut University2312026-10-202026-10-02
Soluble TREM-1 in Diabetes-Associated Cardiovascular Complications
Type 2 Diabetes Mellitus, Cardiovascular Diseases
Not yet recruitingAssiut University852026-10-012026-09-29
Platelet Indices and Blood Groups in Type 2 Diabetes Vascular Complications
Type 2 Diabetes Mellitus, Vascular Complications
Not yet recruitingAssiut University1002026-09-262026-09-29

Showing 20 of 1890. Sign in to see all of them.

Narrower conditions

Diabetes Mellitus, Type 2 (1890)  ·  Diabetes Mellitus (288)  ·  Obesity (136)  ·  Insulin Resistance (113)  ·  Hypertension (45)  ·  Diabetes Mellitus, Type 1 (43)  ·  Cardiovascular Diseases (41)  ·  Renal Insufficiency, Chronic (39)  ·  Motor Activity (37)  ·  Overweight (35)  ·  Glucose Intolerance (30)  ·  Diabetic Nephropathies (24)  ·  Hyperglycemia (23)  ·  Dyslipidemias (19)  ·  Inflammation (19)

Broader conditions

Nutritional and Metabolic Diseases (1887)  ·  Endocrine System Diseases (1877)  ·  Glucose Metabolism Disorders (1877)  ·  Metabolic Diseases (1875)  ·  Diabetes Mellitus (1602)  ·  Pathological Conditions, Signs and Symptoms (260)  ·  Signs and Symptoms (182)  ·  Nutrition Disorders (154)  ·  Body Weight (151)  ·  Overnutrition (149)  ·  Hyperinsulinism (125)  ·  Overweight (114)  ·  Cardiovascular Diseases (107)  ·  Vascular Diseases (99)  ·  Urogenital Diseases (97)

Interventions

Metformin (219)  ·  Sitagliptin Phosphate (119)  ·  Insulin Glargine (100)  ·  glimepiride (62)  ·  Pioglitazone (58)  ·  Insulin (57)  ·  dapagliflozin (57)  ·  Exenatide (54)  ·  Exercise (37)  ·  saxagliptin (36)  ·  Liraglutide (33)  ·  Vildagliptin (30)  ·  lixisenatide (26)  ·  (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (25)  ·  ipragliflozin (25)

Sponsors

AstraZeneca (127)  ·  Merck Sharp & Dohme LLC (108)  ·  Sanofi (80)  ·  Eli Lilly and Company (37)  ·  Takeda (34)  ·  Astellas Pharma Inc (21)  ·  Tanabe Pharma Corporation (21)  ·  Bayer (18)  ·  GlaxoSmithKline (18)  ·  Lexicon Pharmaceuticals (17)  ·  Pfizer (15)  ·  Novartis Pharmaceuticals (14)  ·  Chong Kun Dang Pharmaceutical (13)  ·  Maastricht University Medical Center (13)  ·  Daiichi Sankyo (11)

Countries

United States (565)  ·  China (207)  ·  South Korea (147)  ·  Germany (136)  ·  Canada (130)  ·  Japan (130)  ·  United Kingdom (88)  ·  Mexico (83)  ·  India (78)  ·  Poland (73)  ·  Spain (72)  ·  Italy (71)  ·  Hungary (69)  ·  Denmark (67)  ·  Taiwan (66)

Top investigators

Kazuoki Kondo, MD (14)  ·  James Malone, MD (13)  ·  Lisa Porter, MD (9)  ·  Suman Wason, MD (9)

Results publications

PMID 38770818, PMID 22236356, PMID 31606880, PMID 31797522, PMID 32324065, PMID 32324082, PMID 32372382, PMID 32648108, PMID 34213819, PMID 23748506, PMID 32306296, PMID 32501595, PMID 33166419, PMID 39963952, PMID 22913891, PMID 26894924, PMID 32700393, PMID 33813736, PMID 35210595, PMID 23522121, PMID 30160030, PMID 30366067, PMID 30957581, PMID 31064361, PMID 37526908, PMID 37668888, PMID 39171639, PMID 39531161, PMID 15367925, PMID 17375138, PMID 20092585, PMID 20470226, PMID 20668152, PMID 20807873, PMID 21235696, PMID 22106975, PMID 22405352, PMID 22739142, PMID 23039868, PMID 23536583, PMID 23549864, PMID 23748507, PMID 23986513, PMID 24205974, PMID 24843617, PMID 25537783, PMID 25861982, PMID 28606095, PMID 28774271, PMID 29370218

NIH funding

2017 (14), 2016 (11), 2014 (9), 2025 (7), 2009 (6), 2015 (6), 2019 (5), 2008 (3), 2023 (3), U54RR014616 (3), 2018 (2), K23DK075907 (2), P20GM109096 (2), R01DK082396 (2), R01DK088126 (2)